Zydus Lifesciences Dissolves French Subsidiary Ampliman 2 Susmita Roy11 Jan 2026 10:56 AM ISTNew Delhi: Zydus Lifesciences Ltd has informed that Ampliman 2, France, a step-down wholly owned subsidiary of the company, has been dissolved without...
Zydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes Susmita Roy9 Jan 2026 11:45 PM ISTNew Delhi: Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...
Zydus Lifesciences gets CDSCO Panel nod to study Aprepitant powder for Oral Suspension Dr. Divya Colin20 May 2025 6:15 PM ISTNew Delhi: Granting approval for conducting a bioequivalence (BE) study of Aprepitant powder for Oral Suspension 125 mg, the Subject Expert Committee...
Zydus Lifesciences wins USFDA okay for hypertension drug Valsartan Ruchika Sharma23 July 2024 2:42 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Valsartan...
Zydus Life science's anticancer drug Pertuzumab Gets CDSCO Panel Nod for Additional Indication of Early breast cancer Dr. Divya Colin27 Jun 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Zydus Life...
Zydus Life Science Gets CDSCO Panel Nod To Manufacture and Market Anti-cancer Drug Nelarabine Dr. Divya Colin21 Jun 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Zydus Life Science has got approval from the Subject Expert Committee (SEC) functional under...
Zydus Lifesciences Gets CDSCO Panel nod to study Bivalent Typhoid and Paratyphoid A Conjugate Vaccine Dr. Divya Colin24 April 2024 5:15 PM ISTNew Delhi: Reviewing the Phase I clinical trial protocol of the vaccine Bivalent Typhoid and Paratyphoid A Conjugate Vaccine, the Subject Expert...
Zydus Lifesciences gets CDSCO panel nod to manufacture, market Relugolix Tablets Dr. Divya Colin29 July 2023 6:00 PM ISTNew Delhi: Noting an unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Lifescience Gets CDSCO Panel Nod to Study Aflibercept Dr. Divya Colin7 Jun 2023 6:00 PM ISTNew Delhi: The drug major Zydus Lifescience has got the green signal from the Subject Expert Committee SEC functional under Central Drug Standard...
Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine Dr. Divya Colin15 April 2023 5:15 PM ISTNew Delhi: In response to the drug major Zydus Life Sciences' proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with...
USFDA issues 3 observations for Zydus Lifesciences Ahmedabad facility Ruchika Sharma27 March 2023 2:15 PM ISTThe inspection was a Pre-Approval Inspection as well as a GMP Audit.
